Plaintiffs in the prosed MCL have developed Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) as a result, they claim, of using the glucagon-like peptide-1 receptor agonists Ozempic and/or Wegovy (GLP-1Ras) These drugs, manufactured and sold by Novo Nordisk, Inc
Dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials
AI-enabled in silico approaches, in tandem with high-throughput target binding assays (e.g., small-molecule microarrays) and phenotypic screens (perhaps using cAMP+ as a readout), may further uncover some of these incredibly useful molecules
Why Choose an Arkansas Law Firm for Your GLP-1 Lawsuit
This saves time, reduces unnecessary travel, and makes treatment more convenient
Hoedebecke also says to review your plans formulary every year if youre denied coverage, as policies can change between enrollment cycles What does Ozempic cost with Aetna